What India Needs: Racing to Build Breakthrough Biotech with Dr. Jogin Desai
Send us Fan Mail India spends just 0.7% of its GDP on research and development, compared to 2.5%-5.5% in countries like the US and China. What will it take for India to move from catching up to leading? In this episode, Shutapa Paul speaks with Dr. Jogin Desai, CEO & Founder of Eyestem, as they explore the structural challenges in India’s innovation ecosystem, from limited private risk capital to the gap between research and real-world impact. They also discuss how India...
India spends just 0.7% of its GDP on research and development, compared to 2.5%-5.5% in countries like the US and China.
What will it take for India to move from catching up to leading?
In this episode, Shutapa Paul speaks with Dr. Jogin Desai, CEO & Founder of Eyestem, as they explore the structural challenges in India’s innovation ecosystem, from limited private risk capital to the gap between research and real-world impact.
They also discuss how India is uniquely positioned at a moment in time where global shifts, policy support, and entrepreneurial momentum could unlock a new wave of deep tech innovation.
From reversing vision loss to building scalable and affordable therapies, this conversation looks at what it will take for India to create solutions not just for itself, but for the world.
Tune in to hear insights on biotech, capital, regulation, and the future of innovation in India.
Catch the full conversation on YouTube or listen on Spotify.
#WhatIndiaNeedsPodcast #podcast #innovation #deeptech #biotech #researchanddevelopment #india #healthcareinnovation #startupindia #futureofhealthcare
--------------
00:00:00 - Intro
00:01:12 - Exploring India's R&D spending
00:04:31 - Opportunities in India
00:06:14 - The lack of risk capital
00:08:58 - Challenges in translating academic research to societal impact
00:11:38 - India's $300 billion bioeconomy and moving beyond generics
00:13:30 - The evolution of regulatory standards in India vs. the FDA
00:16:24 - Founding Eyestem and tackling unaffordable therapies
00:24:07 - Future pipeline: Parkinson's, Pulmonary Fibrosis, and more
00:26:09 - The importance of a lean, self-driven innovation team
00:27:24 - Myths about India's originality and lessons from China's biotech sector
00:31:14 - Leapfrogging globally in cell and gene therapy
00:32:46 - AI in biology: Opportunities, hype, and necessary guardrails
00:35:56 - Outro --------------
#innovation #deeptech #biotech #researchanddevelopment #india #healthcareinnovation #startupindia #futureofhealthcare #biotechnology #indiastartups #medtech #scienceandtechnology #globalinnovation
Subscribe to our channel:
Instagram: https://www.instagram.com/shutapapaulpodcast
YouTube: https://www.youtube.com/@Shutapa_Paul
Spotify: https://podcasters.spotify.com/pod/show/the-shutapa-paul-podcast
To know more:
Follow Shutapa Paul on
LinkedIn: https://www.linkedin.com/in/shutapapaul/
Twitter X: https://x.com/ShutapaPaul
Instagram: https://www.instagram.com/shutapa?igsh=MWZ5cHB3aDg3b21jcQ==
Facebook: https://www.facebook.com/shutapapaulpage/
Follow Dr Jogin Desai on
LinkedIn: https://www.linkedin.com/in/jogin-desai/
Twitter X: https://x.com/jogin_desai
Eyestem: https://eyestem.com/